| Name | Title | Contact Details |
|---|
88rising (stylized as 88⬆) is an American mass media company that founded in 2015 by Sean Miyashiro describes as a "hybrid management, record label, video production and marketing company." The company has gained popularity as a musical platform and label for Asian artists such as Keith Ape, Rich Brian, Joji, NIKI, and Higher Brothers. Headquartered in New York City, the company also has offices in Los Angeles and Shanghai. Outside of its core group, the company has collaborated with other artists such as Ghostface Killah, 21 Savage, XXXTentacion, Trippie Redd, Ski Mask the Slump God, Kris Wu, Yaeji, and others.
With Stephen Drotter, author of The Leadership Pipeline and The Performance Pipeline, as Chairman, Leadership Pipeline Institute is the official research institute and leading global provider of solutions based on the two pipeline books, which have sold more than 300,000 copies around the world. The Leadership Pipeline institute is: • The leading global provider of Leadership Pipeline and Specialist Pipeline solutions to private and public organizations • The leading organization for research within the Leadership Pipeline and Specialist Pipeline arena • The global "magnet" for everyone with an interest in the Leadership Pipeline and Specialist concept and how it is applied Today, the Leadership Pipeline is perceived as one of the most influential leadership models through the last two decades. A significant number of the FORTUNE 500 companies have successfully implemented the Leadership Pipeline as their main leadership infrastructure for selecting and growing leaders at all levels and it has seamlessly been applied to corporate, non-profit and public organizations around the world. Leadership Pipeline Institute is specialized in supporting organizations building an internal pipeline of qualified leaders and specialists and in creating empowered, performance- and execution-focused organizations. Working with Leadership Pipeline Institute, you will receive acknowledged hands-on solutions that can be easily customized to your organization and are based on the latest applied global research and experience from some of the worlds most successful companies.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
The mission of Nevada Legal Services is to strengthen the community by ensuring fairness and providing equal access to justice for low income Nevadans. NLS receives the Legal Services Corporation funding for the state of Nevada. We represent qualified individuals in subsidized housing applications, terminations, and eviction, unemployment insurance benefits, Social Security disability appeals, welfare benefits, tax controveries, and limited immigration and family law.